[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:MXCT":3,"prompts:company:0001287098":22,"buybacks:0001287098:12":49,"months:0001287098:36":92,"side:events:0001287098":106,"filings:0001287098":124},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0001287098","MaxCyte, Inc.","MXCT","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:MXCT","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":50,"data_as_of":51,"checked_at":52,"has_active_program":18,"authorized_total":53,"remaining_total":61,"nearest_expiration":64,"programs":67,"recent_quarters":84,"did_asr":15,"asrs":91},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-09-30","2026-11-17T22:52:26.605748Z",{"value":54,"status":55,"as_of":51,"source":56},10000000,"reported",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"0001104659-26-125236","10-Q","2026-11-10","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F1287098\u002F000110465926125236\u002F",{"value":62,"status":55,"as_of":51,"source":63},4500000,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":65,"status":55,"as_of":51,"source":66},"2027-05-05",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},[68],{"authorized":69,"unit":71,"authorized_as_stated":72,"price_as_of":14,"date_authorized":74,"expiration_date":77,"remaining":79,"remaining_as_stated":81,"description":83},{"value":54,"status":55,"as_of":51,"source":70},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"usd",{"value":54,"status":55,"as_of":51,"source":73},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":75,"status":55,"as_of":51,"source":76},"2026-05-12",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":65,"status":55,"as_of":51,"source":78},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":62,"status":55,"as_of":51,"source":80},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":62,"status":55,"as_of":51,"source":82},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"All shares were repurchased pursuant to a $10 million repurchase authorized by our Board and publicly announced on May 12, 2026.",[85],{"period_start":86,"period_end":51,"shares":87,"avg_price":88,"value_usd":89,"source":90},"2026-07-01",2947468,1.36,4008556.4800000004,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},[],{"company":93,"data_as_of":51,"items":94},{"cik":6,"name":7,"ticker":8,"exchange":9},[95,98,103],{"period_start":86,"period_end":96,"open_market_shares":87,"total_shares":87,"program_shares":87,"asr_shares":14,"avg_price":88,"value_usd":89,"remaining":62,"remaining_unit":71,"source":97},"2026-07-31",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"period_start":99,"period_end":100,"open_market_shares":101,"total_shares":101,"program_shares":101,"asr_shares":14,"avg_price":101,"value_usd":101,"remaining":62,"remaining_unit":71,"source":102},"2026-08-01","2026-08-31",0,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"period_start":104,"period_end":51,"open_market_shares":101,"total_shares":101,"program_shares":101,"asr_shares":14,"avg_price":101,"value_usd":101,"remaining":62,"remaining_unit":71,"source":105},"2026-09-01",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"view":107,"sort":108,"total":109,"generated_at":110,"items":111,"next_cursor":14},"all","newest",2,"2026-11-20T09:58:33.467888Z",[112,118],{"id":113,"type":114,"event_date":51,"company":115,"amount_usd":89,"amount_estimated":15,"shares":87,"headline":116,"source":117},"082c6906-ebc8-5281-8838-c6e8c49e1f5e","quarterly_repurchase",{"cik":6,"name":7,"ticker":8,"exchange":9},"MaxCyte, Inc. repurchased 2.9m shares ($4m) in the quarter to Sep 30, 2026",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"id":119,"type":120,"event_date":75,"company":121,"amount_usd":54,"amount_estimated":15,"shares":14,"headline":122,"source":123},"e67dfb6a-779a-5afa-aaf8-99d203c44201","authorization_new",{"cik":6,"name":7,"ticker":8,"exchange":9},"MaxCyte, Inc. authorizes $10m share repurchase program",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"company":125,"items":126,"edgar_url":133},{"cik":6,"name":7,"ticker":8,"exchange":9},[127],{"accession":57,"form":58,"filed_at":128,"period_end":51,"url":60,"used_for":129},"2026-11-10T16:30:36Z",[130,131,132],"programs","recent_quarters","remaining_total","https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0001287098"]